Fertility Supplements
CoQ10, L-Carnitine, Zinc, Folate, Vitamin C, and Vitamin D for Male Fertility
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not FDA approved for fertility (dietary supplements)
Reference only. Not medical advice.
What can go wrong
The main risks are financial and false reassurance rather than physical, though excess can backfire: 'reductive stress' from over-supplementation with antioxidants may theoretically harm sperm, and high-dose zinc can impair copper absorption. The much-cited MOXI trial of antioxidant combination therapy found no improvement in semen parameters or live births. Supplements are unregulated for content and purity, and a man with a correctable cause (varicocele, endocrine, genetic) may waste critical time on pills.
This is something to take to a clinician. The Atlas can tell you what is known about fertility supplements in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A large market of antioxidant and micronutrient supplements is marketed for male fertility, including coenzyme Q10, L-carnitine, zinc, folate, vitamin C, and vitamin D. The rationale is sound in principle: oxidative stress damages sperm membranes and DNA, and antioxidants may counter it. The clinical reality is more modest, most agents show improvements in semen parameters in some trials (evidence level 2-3), but high-quality evidence that supplements increase live births is weak, and a major Cochrane review highlighted low certainty of the underlying studies.
An antioxidant rationale with real biology, and honestly modest, mixed clinical evidence.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Reactive oxygen species in semen, when in excess, peroxidize sperm membrane lipids, impair motility, and fragment sperm DNA. Antioxidants (CoQ10, vitamin C, vitamin E, and others) are hypothesized to neutralize this oxidative load. CoQ10 also participates in mitochondrial energy production relevant to sperm motility; L-carnitine shuttles fatty acids for energy and is concentrated in the epididymis; zinc is a cofactor in spermatogenesis and testosterone metabolism; folate supports DNA synthesis.
What it does to fertility
These supplements target sperm directly and, unlike testosterone therapy, do not suppress spermatogenesis. Zinc and vitamin D status also intersect with testosterone physiology, so correcting documented deficiency may benefit both hormonal and reproductive endpoints. The honest framing is that they are low-risk adjuncts with modest, uncertain benefit, not substitutes for diagnosing a specific cause.
What people get wrong
Often saidFertility supplements are proven to make babies
ActuallySeveral agents improve semen parameters in some trials, but high-quality evidence for increased live births is weak; the MOXI trial found no benefit and Cochrane rated the evidence low-certainty.
Often saidIf some antioxidant is good, more is better
ActuallyExcess antioxidant intake may cause reductive stress and high-dose zinc impairs copper absorption; more is not reliably better.
Often saidSupplements can replace a fertility workup
ActuallyThey cannot diagnose or treat varicocele, endocrine, or genetic causes; relying on them can delay effective treatment.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Typical evidence level
- grade 2-3 (parameter improvement; live-birth data weak)
- CoQ10 common dose studied
- 200-300 mg/day
- L-carnitine common dose studied
- 2-3 g/day
- Zinc role
- Cofactor in spermatogenesis; deficiency associated with low count
- Folate
- Often paired with zinc; mixed RCT results
- Vitamin D
- Associated with motility in observational data; RCTs inconsistent
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Fertility Supplements. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Cochrane review, antioxidants for male subfertility (Smits et al.)2019
Low-certainty evidence that antioxidants may improve live-birth and pregnancy rates in subfertile couples; authors stressed the poor quality and small size of included trials
MOXI randomized trial (Steiner et al.), Fertility and Sterility2020
Antioxidant formulation (including vitamins C, E, selenium, zinc, folate, lycopene, L-carnitine) did not improve semen parameters or live-birth rate versus placebo
Balercia et al., CoQ10 RCT2009
CoQ10 supplementation improved sperm motility in men with idiopathic asthenozoospermia
Lenzi et al., L-carnitine RCT2003
L-carnitine improved sperm motility versus placebo in selected men